A detailed history of Wedmont Private Capital transactions in Viatris Inc stock. As of the latest transaction made, Wedmont Private Capital holds 13,164 shares of VTRS stock, worth $164,813. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,164
Previous 12,177 8.11%
Holding current value
$164,813
Previous $129,000 17.83%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$10.32 - $12.13 $10,185 - $11,972
987 Added 8.11%
13,164 $152,000
Q2 2024

Jul 15, 2024

BUY
$10.05 - $12.02 $122,378 - $146,367
12,177 New
12,177 $129,000
Q1 2023

Apr 11, 2023

BUY
$9.2 - $12.26 $41,814 - $55,721
4,545 Added 29.21%
20,105 $193,000
Q4 2022

Jan 09, 2023

BUY
$8.72 - $11.56 $135,683 - $179,873
15,560 New
15,560 $0
Q2 2022

Jul 11, 2022

BUY
$9.95 - $12.27 $112,574 - $138,822
11,314 New
11,314 $118,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Wedmont Private Capital Portfolio

Follow Wedmont Private Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedmont Private Capital, based on Form 13F filings with the SEC.

News

Stay updated on Wedmont Private Capital with notifications on news.